Murage EN, Schroeder JC, Beinborn M, Ahn JM
Although I do not routinely measure longitudinal change in body composition or bone mass in people taking GLP-1s, mostly because of the cost of DXA scans, significant muscle or bone loss are two objective manifestations of excessive weight loss that should lead to stopping or slowing treatment
Sadly, some providers promote compounded, unapproved injections of Semaglutide or Tirzepatide because theyre cheaper
J Clin Endocrinol Metab, 2021
Hydroxocobalamin injection: Product information
(44) reported that the half-maximal effective concentrations (EC50) of GIP with GIPR and of GLP-1 with GLP-1R are 20 pM and 28 pM, respectively, without exhibiting cross-reactivity